Skip to main content
OpenTrials

Clinical trial condition

Neuromyelitis Optica Spectrum Disorder

Explore clinical trials studying Neuromyelitis Optica Spectrum Disorder. Study availability and eligibility vary by location and protocol.

34 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Neuromyelitis Optica Spectrum Disorder trial results

Not Yet Recruiting

Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Study of Ravulizumab in Chinese Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD)

NCT07557420

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +11 more
Locations
  • Research Site Chengdu, China
  • Research Site Dongguan, China
  • Research Site Shanghai, China
  • Research Site Wenzhou, China
View Trial Details
Completed

An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD

NCT04201262

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Central Nervous System Diseases, +26 more
Locations
  • Research Site Aurora, Colorado, United States
  • Research Site Fort Collins, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Miami, Florida, United States
View all 41 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)

NCT04660539

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +10 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Miami Miami, Florida, United States
  • Columbus Research and Wellness Columbus, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
View all 53 locations
View Trial Details

Related conditions